ARCH-backed Re­silience nabs its lat­est fi­nanc­ing round, putting to­geth­er a mas­sive $625M Se­ries D

4 years ago
Financing
Cell/Gene Tx

FDA ap­proves GSK's MMR vac­cine, the first new green light in more than half a cen­tu­ry

4 years ago
R&D
FDA+

#AS­CO22: Rare bio­mark­er leads to ‘un­prece­dent­ed’ re­sults in small rec­tal can­cer study

4 years ago
R&D

#AS­CO22: BioN­Tech says mR­NA vac­cine safe in 15 of 16 pa­tients with dead­ly pan­cre­at­ic can­cer

4 years ago
R&D

#AS­CO22: In yet an­oth­er sting­ing set­back, Pfiz­er’s block­buster CDK 4/6 fails its lat­est test on sur­vival. But can ...

4 years ago
R&D

#AS­CO22: Merus looks to beat El­e­va­tion to NRG1+ sum­mit as BLA fil­ing ap­proach­es

4 years ago
R&D

#AS­CO22: En­her­tu blows chemother­a­py out of the wa­ter, re­defin­ing breast can­cer sub­groups along the way

4 years ago
R&D

#AS­CO22: Fol­low­ing back-to-back TIG­IT bombs, Roche of­fers in­sight in­to first PhI­II tri­al fail

4 years ago
R&D

#AS­CO22: Leg­end, J&J say Carvyk­ti holds up past the two-year mark as pair preps for po­ten­tial sec­ond nod

4 years ago
R&D
China

#AS­CO22: Gilead’s Trodelvy shows slim ben­e­fit in com­mon form of breast can­cer

4 years ago
R&D

Lat­est news out of #AS­CO22; GSK, Bris­tol My­ers get M&A go­ing in vac­cines, on­col­o­gy; Roche's pact spot­lights new ...

4 years ago
Weekly

#AS­CO22: With me­di­an dura­bil­i­ty da­ta, Cul­li­nan aims to 'dis­tin­guish it­self' from Takeda's Exkiv­i­ty and J&J's ...

4 years ago
R&D

#AS­CO22: Un­con­cerned with lat­er mar­ket en­try, Ar­cel­lx on the up with new BC­MA CAR-T da­ta

4 years ago
R&D

Can wear­ables help Parkin­son's pa­tients? Ver­i­ly pub­lish­es new da­ta from vir­tu­al ex­ams

4 years ago
R&D
Pharma

Sanofi changes up menin­gi­tis cam­paign — and celeb am­bas­sadors — to re­flect shift in vac­ci­na­tion gap

4 years ago
Pharma
Marketing

CDC treats first mon­key­pox pa­tient with SIGA's small­pox an­tivi­ral via ex­pand­ed ac­cess

4 years ago
Pharma

Jazz Phar­ma­ceu­ti­cals taps celebri­ty ac­tor and epilep­sy ad­vo­cate to host YouTube ‘Care Giv­er’ se­ries

4 years ago
Pharma
Marketing

State supreme court rules in fa­vor of Eli Lil­ly in case over warn­ing pa­tients of risks when DTC ads are in play

4 years ago
Pharma
Law

FDA re­view spot­lights risk of heart in­flam­ma­tion linked to No­vavax's Covid vac­cine — shares tum­ble

4 years ago
FDA+
Coronavirus

#AS­CO22: Im­bru­vi­ca keeps ag­gres­sive blood can­cer at bay for 6+ years, but miss­es the mark in over­all sur­vival

4 years ago
R&D
Pharma

Bioethi­cists weigh in: Xeno­trans­plan­ta­tion may be here ‘with­in the next five years,’ but con­cerns loom

4 years ago
R&D

Im­mu­nic shares cut in half as biotech dumps ul­cer­a­tive col­i­tis af­ter PhII fail

4 years ago
R&D

Boehringer In­gel­heim inks deal for tar­get­ed can­cer an­ti­bod­ies from Sin­ga­pore re­search org

4 years ago
Deals
R&D

De­spite a PhI­II fail, Bio­gen push­es ALS drug tofersen for­ward with new analy­sis in move echo­ing Aduhelm

4 years ago
R&D
First page Previous page 519520521522523524525 Next page Last page
A service from the Financial Times